Morgan Stanley’s BioLineRX BLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.05K Sell
1,543
-701
-31% -$3.2K ﹤0.01% 6943
2025
Q1
$6.64K Buy
2,244
+266
+13% +$787 ﹤0.01% 6918
2024
Q4
$16.9K Sell
1,978
-2,960
-60% -$25.3K ﹤0.01% 6621
2024
Q3
$106K Buy
4,938
+3,227
+189% +$69.2K ﹤0.01% 5984
2024
Q2
$39K Sell
1,711
-5,573
-77% -$127K ﹤0.01% 6247
2024
Q1
$326K Sell
7,284
-4,629
-39% -$207K ﹤0.01% 5518
2023
Q4
$748K Buy
11,913
+7,519
+171% +$472K ﹤0.01% 5440
2023
Q3
$320K Sell
4,394
-2,130
-33% -$155K ﹤0.01% 5368
2023
Q2
$416K Buy
6,524
+101
+2% +$6.44K ﹤0.01% 5303
2023
Q1
$228K Buy
6,423
+99
+2% +$3.51K ﹤0.01% 5658
2022
Q4
$149K Sell
6,324
-240
-4% -$5.66K ﹤0.01% 5790
2022
Q3
$243K Buy
6,564
+259
+4% +$9.59K ﹤0.01% 5635
2022
Q2
$323K Sell
6,305
-483
-7% -$24.7K ﹤0.01% 5643
2022
Q1
$464K Buy
6,788
+284
+4% +$19.4K ﹤0.01% 5446
2021
Q4
$531K Buy
6,504
+501
+8% +$40.9K ﹤0.01% 5507
2021
Q3
$660K Buy
6,003
+332
+6% +$36.5K ﹤0.01% 5329
2021
Q2
$637K Sell
5,671
-4,289
-43% -$482K ﹤0.01% 5375
2021
Q1
$1.11M Sell
9,960
-8,345
-46% -$932K ﹤0.01% 4655
2020
Q4
$1.85M Sell
18,305
-903
-5% -$91K ﹤0.01% 4230
2020
Q3
$1.26M Buy
19,208
+5,080
+36% +$333K ﹤0.01% 4039
2020
Q2
$966K Buy
14,128
+5,530
+64% +$378K ﹤0.01% 4205
2020
Q1
$457K Buy
8,598
+2,198
+34% +$117K ﹤0.01% 4431
2019
Q4
$576K Buy
6,400
+2,765
+76% +$249K ﹤0.01% 4848
2019
Q3
$384K Buy
3,635
+1,265
+53% +$134K ﹤0.01% 4810
2019
Q2
$519K Buy
2,370
+797
+51% +$175K ﹤0.01% 4590
2019
Q1
$406K Sell
1,573
-66
-4% -$17K ﹤0.01% 4678
2018
Q4
$430K Buy
1,639
+37
+2% +$9.71K ﹤0.01% 4881
2018
Q3
$1.03M Sell
1,602
-83
-5% -$53.3K ﹤0.01% 4513
2018
Q2
$900K Sell
1,685
-194
-10% -$104K ﹤0.01% 4692
2018
Q1
$981K Buy
1,879
+138
+8% +$72K ﹤0.01% 4555
2017
Q4
$1.14M Buy
1,741
+233
+15% +$152K ﹤0.01% 4451
2017
Q3
$1.01M Buy
1,508
+167
+12% +$112K ﹤0.01% 4418
2017
Q2
$680K Buy
1,341
+62
+5% +$31.4K ﹤0.01% 4621
2017
Q1
$737K Buy
1,279
+252
+25% +$145K ﹤0.01% 4599
2016
Q4
$567K Buy
1,027
+108
+12% +$59.6K ﹤0.01% 4864
2016
Q3
$634K Buy
919
+112
+14% +$77.3K ﹤0.01% 4373
2016
Q2
$387K Buy
807
+86
+12% +$41.2K ﹤0.01% 4579
2016
Q1
$441K Sell
721
-41
-5% -$25.1K ﹤0.01% 4527
2015
Q4
$594K Sell
762
-122
-14% -$95.1K ﹤0.01% 4410
2015
Q3
$812K Sell
884
-30
-3% -$27.6K ﹤0.01% 4280
2015
Q2
$1.46M Buy
914
+342
+60% +$546K ﹤0.01% 3913
2015
Q1
$725K Buy
572
+527
+1,171% +$668K ﹤0.01% 4371
2014
Q4
$44K Buy
45
+28
+165% +$27.4K ﹤0.01% 5847
2014
Q3
$16K Hold
17
﹤0.01% 6075
2014
Q2
$21K Buy
17
+1
+6% +$1.24K ﹤0.01% 6014
2014
Q1
$21K Buy
+16
New +$21K ﹤0.01% 5951